MAEZENT Trademark

Trademark Overview


On Monday, January 8, 2018, a trademark application was filed for MAEZENT with the United States Patent and Trademark Office. The USPTO has given the MAEZENT trademark a serial number of 87746788. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 29, 2020. This trademark is owned by Novartis AG. The MAEZENT trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preve...
maezent

General Information


Serial Number87746788
Word MarkMAEZENT
Filing DateMonday, January 8, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 29, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 22, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, June 29, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 29, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 24, 2019EXTENSION 3 GRANTED
Sunday, November 24, 2019EXTENSION 3 FILED
Sunday, November 24, 2019TEAS EXTENSION RECEIVED
Wednesday, May 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 27, 2019EXTENSION 2 GRANTED
Monday, May 27, 2019EXTENSION 2 FILED
Monday, May 27, 2019TEAS EXTENSION RECEIVED
Tuesday, November 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 24, 2018EXTENSION 1 GRANTED
Saturday, November 24, 2018EXTENSION 1 FILED
Saturday, November 24, 2018TEAS EXTENSION RECEIVED
Tuesday, May 29, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 26, 2018ASSIGNED TO EXAMINER
Monday, January 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 11, 2018NEW APPLICATION ENTERED IN TRAM